SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-21-000092
Filing Date
2021-07-12
Accepted
2021-07-12 16:05:48
Documents
3
Period of Report
2021-07-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant_xinducementxgrantxp.htm 8-K 29595
2 EX-10.1 opiantpharmaceuticals-2021.htm EX-10.1 158194
3 EX-99.1 opntpressreleasecco_jul202.htm EX-99.1 10350
  Complete submission text file 0001385508-21-000092.txt   199642
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 211085602
SIC: 2834 Pharmaceutical Preparations